Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
07/2010
07/21/2010CN101780145A Medical stone mineral health-care product
07/21/2010CN101780137A Processing method of honey-fried liquorice
07/21/2010CN101780065A Application of calcium disodium edetate in preparation of medicine for inhibiting connective tissue growth factor and monoamine oxidase of human beings and mammal
07/21/2010CN101780064A New application of p-hydroxyl cinnamic acid
07/21/2010CN101780037A Dipyridamole self-emulsifying medicament administration system and preparation method thereof
07/21/2010CN101779791A Composition with health care functions and preparation method thereof
07/21/2010CN101181596B Chinese medicine composition orally taken for curing bronchiolectasis
07/21/2010CN101125199B Application of interleukin 2 in preparing medicine for treating rhinitis
07/21/2010CN101019898B Crushing method and preparation of aweto
07/21/2010CN101011414B Improved lung-brain composition medicine
07/20/2010US7759486 2,4,5-Trisubstituted pyrimidine compounds
07/20/2010US7759399 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance
07/20/2010US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain
07/20/2010US7759388 Phenylalanine derivatives
07/20/2010US7759380 Substituted pyrrolines as kinase inhibitors
07/20/2010US7759364 Method for producing non-hydrated fexofenadine hydrochloride and a novel crystalline form obtained thereby
07/20/2010US7759355 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine
07/20/2010US7759343 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
07/20/2010US7759342 such as 8-(2-Fluorophenylamino)-2-(4-methoxyphenylamino)-9-(trans-4-(methylamino)cyclohexyl)-9H-purine, used for for inhibiting neutrophil accumulation in bronchoalveolar lavage fluid
07/20/2010US7759328 Formeratol and budesonide for treatment of respiratory system disorders such as chronc obstructive pulmonary disease
07/20/2010US7759326 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
07/20/2010US7759323 Highly purified antiendotoxin compound
07/20/2010CA2547234C The use of quaternary pyridinium salts as vasoprotective agents
07/20/2010CA2448798C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1)
07/20/2010CA2447865C Novel sulfonic acid derivatives
07/20/2010CA2197235C Adenovirus comprising a gene coding for glutathion peroxidase
07/17/2010WO2010067131A1 P38 map kinase inhibitors
07/15/2010WO2010080572A1 Treatment or prevention of viral infection by chlorination
07/15/2010WO2010079668A1 Olefin compound
07/15/2010WO2010079420A1 Use of deuterium oxide for treating viral diseases of the respiratory tract
07/15/2010WO2010079305A1 Anti-snoring composition containing a thermogelling polymer
07/15/2010WO2010078953A1 Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd
07/15/2010US20100179203 Novel pyrazole derivatives useful as potassium channel modulators
07/15/2010US20100179167 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
07/15/2010US20100179143 Naphthyridine, derivatives as p13 kinase inhibitors
07/15/2010US20100179141 Novel jnk inhibitors
07/15/2010US20100179139 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments
07/15/2010US20100179124 Thieno-pyridine derivatives as mek inhibitors
07/15/2010US20100179103 Curcumin cyclodextrin combination for preventing or treating various diseases
07/15/2010US20100179095 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa
07/15/2010US20100178331 Preparation for transnasal application
07/15/2010US20100178296 Antibodies to cd200r
07/15/2010US20100178288 Use of aphanamixis polystacha extracts or fractions against 5-lipoxygenase mediated diseases
07/15/2010US20100178243 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
07/15/2010DE102009004197A1 Heterocyclisch anellierte Diaryldihydropyrimidin-Derivate und ihre Verwendung Fused heterocyclic derivatives and their use Diaryldihydropyrimidin
07/14/2010EP2206720A1 Albumin fusion proteins
07/14/2010EP2206712A1 "Alkaloid aminoester derivatives and medicinal composition thereof"
07/14/2010EP2206711A2 Tetomilast polymorphs
07/14/2010EP2206698A1 Ethynylindole compounds
07/14/2010EP2206512A2 Increase of interferon-beta for anti-virus therapy for respiratory diseases
07/14/2010EP2206511A1 Protein a compositions and methods of use
07/14/2010EP2205640A2 Antibodies that bind il-4 and/or il-13 and their uses
07/14/2010EP2205607A1 Thienopyrimidine compounds
07/14/2010EP2205585A1 Quinoline derivatives used to treat inflammatory and allergic diseases
07/14/2010EP2205570A1 2-s-benzyl substituted pyrimidines as crth2 antagonists
07/14/2010EP2205254A1 Method of producing plant extract formulations
07/14/2010EP2205248A2 Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease
07/14/2010EP2205241A1 Polo-like kinase inhibitors
07/14/2010EP1486494B1 N-substituted benzothiophenesulfonamide derivative
07/14/2010CN1823063B Quinoline derivatives as phosphodiesterase inhibitors
07/14/2010CN101778830A Particulates of a crth2 antagonist
07/14/2010CN101773618A Drug for treatment of cold
07/14/2010CN101773617A Drug for treatment of asthmatic bronchitis
07/14/2010CN101773603A Chinese medicine preparation for treating acute pharyngitis
07/14/2010CN101773601A Throat-care granules in bag for treatment of pharyngitis
07/14/2010CN101773599A Drug for treatment of upper respiratory tract infection
07/14/2010CN101773598A Chinese medicine composition for treating chronic sore throat and preparation method thereof
07/14/2010CN101773587A Drug for treatment of bronchitis
07/14/2010CN101773582A Drug for treatment of chronic bronchitis
07/14/2010CN101773580A Traditional Chinese medicine composition for curing infantile acute bronchitis and preparation method
07/14/2010CN101773578A Vitex oil nanoemulsion and preparation method thereof
07/14/2010CN101773569A Oral Chinese medicine liquid for treating chicken infectious laryngotracheitis
07/14/2010CN101773563A Medicine composition
07/14/2010CN101773560A Method for testing quality of Nguyen supernatant pills
07/14/2010CN101773549A Drug pillow preparation for curing nasitis and preparation method thereof
07/14/2010CN101773541A Yupingfeng soft capsule
07/14/2010CN101773538A External application medicine for treating acute pharyngitis
07/14/2010CN101773534A Quality detection method for tablets for treating influenza and inflammation
07/14/2010CN101773532A Carpesium abrotanoides total terpene lactones extract
07/14/2010CN101773518A Medicine for treating infectious diseases
07/14/2010CN101773504A Micronized cefditoren pivoxil composition
07/14/2010CN101773503A Leukotriene antagonist and antihistaminics composition
07/14/2010CN101773492A Medicine for treating acute bronchitis and preparation method thereof
07/14/2010CN101773481A Chewable tablet containing montelukast sodium
07/14/2010CN101773478A Pulmonary targeting microsphere of veterinary ceftiofur hydrochloride and preparation method thereof
07/14/2010CN101244101B Chinese medicine composition for curing rhinitis
07/14/2010CN101204513B Peroral Chinese traditional medicine composition for emphysema
07/14/2010CN101129473B Radix fici simplicissimatis extractive and method of producing the same and use thereof
07/14/2010CN101108809B 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists
07/13/2010US7756643 Method for determining the biological effect and/or activity of at least one drug, chemical substances and/or pharmaceutical composition based on their effect on the methylation status of DNA
07/13/2010US7754856 Human sodium-dependent bile acid transporter proteins
07/13/2010US7754769 reducing pro-inflammatory response in diseased cell of respiratory tract by contacting cell with an agent that increases ceramide levels in cell thereby reducing pro-inflammatory response in cell, wherein agent is fenretinide and diseased cell is representative of disease state of cystic fibrosis
07/13/2010US7754751 Preferential inhibition of release of pro-inflammatory cytokines
07/13/2010US7754750 a -5 substituted 1-H,3-H-imidazolidine-2,4-dione such as 5-(2-{[4-(4'-fluoro[1,1'-biphenyl]-4-yl)-1-piperazinyl]sulfonyl}ethyl)-2,4-imidazolidinedione; protease inhibitors, especially metalloelastase (MMP12)
07/13/2010US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
07/13/2010US7754732 such as 4-Oxo-2-phenyl-1,3,8-triaza-spiro[4,5]dec-1-ene-8-carboxylic acid{1-7-methyl-1H-indazol-5-yl methyl)-2-[1,4]bipiperidinyl-1'-yl-2-oxo-ethyl}-amide, used as antagonists of calcitonin gene-related peptide receptors; used in the therapy of headaches and respiratory system disorders
07/13/2010US7754728 Adenine compound and use thereof
07/13/2010US7754682 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
07/13/2010US7754228 Cytotoxic T-cell epitopes from Chlamydia
07/13/2010US7754205 Composition for transmucosal administration containing conenzyme Q as the active ingredient
1 ... 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 ... 878